FI60708C - Foerfarande foer framstaellning av neuroleptiska 2-(4-fenyl-4-cyanobutyl)-1,2,3,4-tetrahydro-5(h)pyrido(4,3-b)-indoler - Google Patents
Foerfarande foer framstaellning av neuroleptiska 2-(4-fenyl-4-cyanobutyl)-1,2,3,4-tetrahydro-5(h)pyrido(4,3-b)-indoler Download PDFInfo
- Publication number
- FI60708C FI60708C FI771306A FI771306A FI60708C FI 60708 C FI60708 C FI 60708C FI 771306 A FI771306 A FI 771306A FI 771306 A FI771306 A FI 771306A FI 60708 C FI60708 C FI 60708C
- Authority
- FI
- Finland
- Prior art keywords
- tetrahydro
- pyrido
- cyanobutyl
- neuroleptic
- phenyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- -1 4-PHENYL-4-CYANOBUTYL Chemical class 0.000 title claims description 6
- 230000000701 neuroleptic effect Effects 0.000 title claims description 6
- 239000003176 neuroleptic agent Substances 0.000 title claims description 4
- 235000013399 edible fruits Nutrition 0.000 title 1
- 239000002253 acid Substances 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- RDMFHRSPDKWERA-UHFFFAOYSA-N 5H-Pyrido[4,3-b]indole Chemical class C1=NC=C2C3=CC=CC=C3NC2=C1 RDMFHRSPDKWERA-UHFFFAOYSA-N 0.000 claims description 2
- NJBMMMJOXRZENQ-UHFFFAOYSA-N 6H-pyrrolo[2,3-f]quinoline Chemical compound c1cc2ccc3[nH]cccc3c2n1 NJBMMMJOXRZENQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 2
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229960004046 apomorphine Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 2
- FFSAXUULYPJSKH-UHFFFAOYSA-N butyrophenone Chemical class CCCC(=O)C1=CC=CC=C1 FFSAXUULYPJSKH-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- HYOAGWAIGJXNQH-UHFFFAOYSA-N 1-bromo-1-chloropropane Chemical compound CCC(Cl)Br HYOAGWAIGJXNQH-UHFFFAOYSA-N 0.000 description 1
- FEUBVJZHCNMKFH-UHFFFAOYSA-N 5-chloro-2-(4-fluorophenyl)pentanenitrile Chemical compound FC1=CC=C(C(CCCCl)C#N)C=C1 FEUBVJZHCNMKFH-UHFFFAOYSA-N 0.000 description 1
- DAGARRGOFWIELB-UHFFFAOYSA-N C(C)P(O)(=O)O.C(CCC)(=O)O Chemical compound C(C)P(O)(=O)O.C(CCC)(=O)O DAGARRGOFWIELB-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 229940054053 antipsychotics butyrophenone derivative Drugs 0.000 description 1
- 238000009227 behaviour therapy Methods 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- XRKQMIFKHDXFNQ-UHFFFAOYSA-N n-cyclohexyl-n-ethylcyclohexanamine Chemical compound C1CCCCC1N(CC)C1CCCCC1 XRKQMIFKHDXFNQ-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical class N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003459 sulfonic acid esters Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2621729 | 1976-05-15 | ||
| DE19762621729 DE2621729A1 (de) | 1976-05-15 | 1976-05-15 | Neue 2-(4-phenyl-4-cyanobutyl)-1,2, 3,4-tetrahydro-5(h)-pyrido- eckige klammer auf 4,3-b eckige klammer zu -indole und verfahren zu ihrer herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI771306A7 FI771306A7 (enExample) | 1977-11-16 |
| FI60708B FI60708B (fi) | 1981-11-30 |
| FI60708C true FI60708C (fi) | 1982-03-10 |
Family
ID=5978115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI771306A FI60708C (fi) | 1976-05-15 | 1977-04-25 | Foerfarande foer framstaellning av neuroleptiska 2-(4-fenyl-4-cyanobutyl)-1,2,3,4-tetrahydro-5(h)pyrido(4,3-b)-indoler |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4085216A (enExample) |
| JP (1) | JPS52139099A (enExample) |
| AU (1) | AU506230B2 (enExample) |
| BE (1) | BE854643A (enExample) |
| CA (1) | CA1069508A (enExample) |
| CH (1) | CH632269A5 (enExample) |
| DE (1) | DE2621729A1 (enExample) |
| DK (1) | DK142115C (enExample) |
| ES (1) | ES458810A1 (enExample) |
| FI (1) | FI60708C (enExample) |
| FR (1) | FR2351116A1 (enExample) |
| GB (1) | GB1553645A (enExample) |
| GR (1) | GR66106B (enExample) |
| IE (1) | IE44951B1 (enExample) |
| IL (1) | IL52086A (enExample) |
| LU (1) | LU77333A1 (enExample) |
| MX (1) | MX4289E (enExample) |
| NL (1) | NL7705305A (enExample) |
| NO (1) | NO146240C (enExample) |
| NZ (1) | NZ184095A (enExample) |
| PH (1) | PH12203A (enExample) |
| PT (1) | PT66546B (enExample) |
| SE (1) | SE432422B (enExample) |
| ZA (1) | ZA772855B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4636563A (en) * | 1985-09-16 | 1987-01-13 | American Home Products Corporation | Antipsychotic γ-carbolines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6909M (enExample) * | 1966-12-07 | 1969-04-28 |
-
1976
- 1976-05-15 DE DE19762621729 patent/DE2621729A1/de not_active Withdrawn
-
1977
- 1977-04-25 FI FI771306A patent/FI60708C/fi not_active IP Right Cessation
- 1977-05-03 GR GR53348A patent/GR66106B/el unknown
- 1977-05-09 US US05/794,937 patent/US4085216A/en not_active Expired - Lifetime
- 1977-05-12 MX MX775738U patent/MX4289E/es unknown
- 1977-05-12 CH CH596977A patent/CH632269A5/de not_active IP Right Cessation
- 1977-05-13 JP JP5520377A patent/JPS52139099A/ja active Pending
- 1977-05-13 LU LU77333A patent/LU77333A1/xx unknown
- 1977-05-13 IE IE984/77A patent/IE44951B1/en unknown
- 1977-05-13 SE SE7705633A patent/SE432422B/xx unknown
- 1977-05-13 NL NL7705305A patent/NL7705305A/xx not_active Application Discontinuation
- 1977-05-13 NO NO771695A patent/NO146240C/no unknown
- 1977-05-13 AU AU25130/77A patent/AU506230B2/en not_active Expired
- 1977-05-13 IL IL52086A patent/IL52086A/xx unknown
- 1977-05-13 GB GB20295/77A patent/GB1553645A/en not_active Expired
- 1977-05-13 BE BE177588A patent/BE854643A/xx not_active IP Right Cessation
- 1977-05-13 PH PH19767A patent/PH12203A/en unknown
- 1977-05-13 NZ NZ184095A patent/NZ184095A/xx unknown
- 1977-05-13 ZA ZA00772855A patent/ZA772855B/xx unknown
- 1977-05-13 FR FR7714796A patent/FR2351116A1/fr active Granted
- 1977-05-13 CA CA278,323A patent/CA1069508A/en not_active Expired
- 1977-05-13 DK DK211077A patent/DK142115C/da not_active IP Right Cessation
- 1977-05-13 PT PT66546A patent/PT66546B/pt unknown
- 1977-05-14 ES ES458810A patent/ES458810A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US4085216A (en) | 1978-04-18 |
| BE854643A (fr) | 1977-11-14 |
| FI771306A7 (enExample) | 1977-11-16 |
| NO146240B (no) | 1982-05-18 |
| SE432422B (sv) | 1984-04-02 |
| IE44951B1 (en) | 1982-05-19 |
| DK142115C (da) | 1981-02-02 |
| NO771695L (no) | 1977-11-16 |
| DK211077A (da) | 1977-11-16 |
| IE44951L (en) | 1977-11-15 |
| PT66546A (de) | 1977-06-01 |
| CA1069508A (en) | 1980-01-08 |
| MX4289E (es) | 1982-03-16 |
| AU506230B2 (en) | 1979-12-20 |
| NZ184095A (en) | 1979-08-31 |
| SE7705633L (sv) | 1977-11-16 |
| JPS52139099A (en) | 1977-11-19 |
| IL52086A (en) | 1979-12-30 |
| NO146240C (no) | 1982-08-25 |
| FI60708B (fi) | 1981-11-30 |
| DE2621729A1 (de) | 1977-12-08 |
| GB1553645A (en) | 1979-09-26 |
| GR66106B (enExample) | 1981-01-16 |
| PH12203A (en) | 1978-11-28 |
| LU77333A1 (enExample) | 1978-06-26 |
| NL7705305A (nl) | 1977-11-17 |
| ES458810A1 (es) | 1978-03-16 |
| AU2513077A (en) | 1978-11-16 |
| ZA772855B (en) | 1979-01-31 |
| DK142115B (da) | 1980-09-01 |
| FR2351116A1 (fr) | 1977-12-09 |
| IL52086A0 (en) | 1977-07-31 |
| FR2351116B1 (enExample) | 1980-04-18 |
| PT66546B (de) | 1979-04-12 |
| CH632269A5 (de) | 1982-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4500525A (en) | Pharmacologically active pyrazolo/4,3-c/pyridines | |
| FI66865C (fi) | Foerfarande foer framstaellning av pyrimido(6,1-a)isokinolin-2,4-dioner | |
| US3714149A (en) | Pyridobenzodiazepinones | |
| US4025513A (en) | Synthesis for the preparation of tetracyclic compounds | |
| SK17702002A3 (sk) | Tienodibenzoazulénové zlúčeniny ako inhibítory rakovinových nekróz | |
| CA1082699A (en) | Fused pyrimidine derivatives and process for the preparation thereof | |
| US4104390A (en) | Thieno [2,3-c] and [3,2-c] pyridines | |
| SU566524A3 (ru) | Способ получени производных пиридо(1,2-а)-пиримидина или их солей | |
| FI71936C (fi) | Foerfarande foer framstaellning av neuroleptiskt aktiva 2-substituerade-8-fluor-5-(4-fluorfenyl)-2,3,4,4a, 5,9b-hexahydro-4a,9b-trans-1h-pyrido/4,3-b/indolderivat. | |
| FI60708C (fi) | Foerfarande foer framstaellning av neuroleptiska 2-(4-fenyl-4-cyanobutyl)-1,2,3,4-tetrahydro-5(h)pyrido(4,3-b)-indoler | |
| NZ205513A (en) | Isoquinoline-4-carboxylic acid derivatives and pharmaceutical compositions containing such | |
| US3751417A (en) | 1-acyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)indolines | |
| US6066667A (en) | Substituted furanones, compositions and antiarthritic use | |
| CA1046515A (en) | 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof | |
| US3518270A (en) | 6,7,12,13 - tetrahydro - 6,12 - imino - 5h - benzo(5,6)cyclooct(1,2 - b)indole derivatives and process for their production | |
| US4381305A (en) | Ethylenediamine derivatives and pharmaceutical compositions containing same | |
| EP0073645B1 (en) | 2-cyclic amino-2-(1,2-benzisoxazol-3-yl)acetic acid ester derivatives, process for the preparation thereof and composition containing the same | |
| US3590034A (en) | Amides derived from piperazine-1-acetic acid and esters thereof and process for obtaining same | |
| NO169771B (no) | Analogifremgangsmaate for fremstilling av polycykliske forbindelser med biocid aktivitet | |
| McQuaid et al. | Substituted 5-amino-4, 5, 6, 7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity | |
| US4431664A (en) | Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical composition therefrom | |
| US4452982A (en) | Process for the preparation of nitrogen-bridgehead condensed pyrimidine compounds, and pharmaceutical compositions containing them | |
| FI60561B (fi) | Foerfarande foer framstaellning av antiinflammatoriska 6,7-dimetoxi-1,2,3,4-tetrahydro-1-isokinolinacetami-dderivat | |
| EP0213450B1 (en) | Aminoacyl derivatives of 4,9-dihydro-10H-pyrido[3,2-b]-thieno-[3,2-e][1,4]diazepinone and of 4,9-dihydro-10H-pyrido[3,2-b]-thieno[3,4-e][1,4]diazepinone, their preparation and pharmaceutical compositions containing them | |
| US4327095A (en) | Methoxy derivatives of 1,4-dithiepino-[2,3-c]-pyrrole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: C.H. BOEHRINGER SOHN |